\-\ Texto\\:\\ \ \(0\)\
\-\ syringomyelia\ \(50\)\
\-\ hydromyelia\ \(19\)\
\-\ neoplastic\\ cyst\ \(0\)\
\-\ myelomalacia\ \(13\)\
\-\ patient\\ was\\ asymptomatic\\ therefore\\ required\\ no\\ treatment\\ for\\ syrinx\\ or\\ chiari\\ i\\.\ \(0\)\
\-\ is\\ pending\\ neuro\\ surgery\\ evaluation\\ for\\ sponduloarthropathy\\/nerve\\ root\\ compromise\\.\ \(0\)\
\-\ cervical\\ spine\\ mr\\:\\ the\\ most\\ concerning\\ finding\\ is\\ a\\ syrinx\\ within\\ the\\ substance\\ of\\ the\\ cervical\\ spinal\\ cord\\,\\ extending\\ from\\ the\\ base\\ of\\ the\\ dens\\ to\\ the\\ c5\\-6\\ level\\.\\ \\ the\\ syrinx\\ measures\\ approximately\\ \\ 7\\.8\\ cm\\ superior\\ to\\ inferior\\ with\\ a\\ maximum\\ diameter\\ of\\ 6\\ mm\\.\\ \\ the\\ caliber\\ of\\ the\\ spinal\\ cord\\ is\\ not\\ significantly\\ expanded\\.\\ \\ there\\ is\\ also\\ significantly\\ low\\-lying\\ cerebellar\\ tonsils\\ descending\\ through\\ the\\ foramen\\ magnum\\ by\\ approximately\\ 14\\ mm\\.\\ \\ the\\ cerebellar\\ tonsils\\ appear\\ pegged\\ and\\ the\\ structures\\ at\\ the\\ level\\ of\\ the\\ foramen\\ magnum\\ are\\ significantly\\ congested\\.\\ \\ there\\ is\\ no\\ pathologic\\ enhancement\\ following\\ gadolinium\\-dtpa\\.\\ \\ the\\ remainder\\ of\\ the\\ exam\\ demonstrated\\ multilevel\\ cervical\\ spondyloarthropathy\\ compounded\\ by\\ developmentally\\ narrowed\\ central\\ bony\\ canal\\ \\(secondary\\ to\\ short\\ pedicles\\)\\ with\\ potential\\ compromise\\ of\\ the\\ left\\ c7\\ nerve\\ root\ \(0\)\
\-\ syrinx\\ associated\\ with\\ chiari\\ i\\ malformation\ \(0\)\
\-\ see\\ factoid\ \(116\)\
\-\ 52\\ y\\/o\\ male\\ who\\ fell\\ on\\ his\\ left\\ side\\ of\\ body\\ three\\ weeks\\ prior\\ with\\ persistent\\ cervical\\ pain\\ and\\ left\\ upper\\ extremity\\ radiculopathy\\.\\ \\ rule\\-out\\ hnp\\.\ \(0\)\
\-\ see\\ factoid\ \(116\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ syrinx\\:\\ 0\\.11506484363031522\ \(0\)\
\-\ significantly\\:\\ 0\\.06592262061521882\ \(0\)\
\-\ cervical\\:\\ 0\\.06241389761993223\ \(0\)\
\-\ magnum\\:\\ 0\\.055108682550666276\ \(0\)\
\-\ tonsils\\:\\ 0\\.05408574089931007\ \(0\)\
\-\ chiari\\:\\ 0\\.053457395603015254\ \(0\)\
\-\ compromise\\:\\ 0\\.05203952024361922\ \(0\)\
\-\ root\\:\\ 0\\.04430953946434417\ \(0\)\
\-\ sponduloarthropathy\\/nerve\\:\\ 0\\.044299087557620596\ \(0\)\
\-\ pegged\\:\\ 0\\.044299087557620596\ \(0\)\
\-\ foramen\\:\\ 0\\.04099819070926636\ \(0\)\
\-\ compounded\\:\\ 0\\.04081593589651534\ \(0\)\
\-\ low\\-lying\\:\\ 0\\.03877842279044416\ \(0\)\
\-\ myelomalacia\\:\\ 0\\.03733278423541009\ \(0\)\
\-\ gadolinium\\-dtpa\\:\\ 0\\.03733278423541009\ \(0\)\
\-\ cerebellar\\:\\ 0\\.0370414041109892\ \(0\)\
\-\ hydromyelia\\:\\ 0\\.03529527112933891\ \(0\)\
\-\ developmentally\\:\\ 0\\.03452064459754364\ \(0\)\
\-\ rule\\-out\\:\\ 0\\.03452064459754364\ \(0\)\
\-\ hnp\\:\\ 0\\.03452064459754364\ \(0\)\
\-\ congested\\:\\ 0\\.03384963257430484\ \(0\)\
\-\ 7\\.8\\:\\ 0\\.03325775802326773\ \(0\)\
\-\ spondyloarthropathy\\:\\ 0\\.03325775802326773\ \(0\)\
\-\ dens\\:\\ 0\\.03272830819584147\ \(0\)\
\-\ pedicles\\:\\ 0\\.03272830819584147\ \(0\)\
\-\ cord\\:\\ 0\\.032634913770908554\ \(0\)\
\-\ mm\\:\\ 0\\.03157985082206036\ \(0\)\
\-\ spinal\\:\\ 0\\.030751519702307398\ \(0\)\
\-\ substance\\:\\ 0\\.030690795089770292\ \(0\)\
\-\ expanded\\:\\ 0\\.030690795089770292\ \(0\)\
\-\ syringomyelia\\:\\ 0\\.030366480913199583\ \(0\)\
\-\ multilevel\\:\\ 0\\.030366480913199583\ \(0\)\
\-\ factoid\\:\\ 0\\.030104879332805395\ \(0\)\
\-\ i\\.\\:\\ 0\\.029245156534736215\ \(0\)\
\-\ c5\\-6\\:\\ 0\\.02792674314545234\ \(0\)\
\-\ c7\\:\\ 0\\.027207643428665038\ \(0\)\
\-\ approximately\\:\\ 0\\.026571033432719427\ \(0\)\
\-\ narrowed\\:\\ 0\\.025889230039381168\ \(0\)\
\-\ see\\:\\ 0\\.025630323730942595\ \(0\)\
\-\ maximum\\:\\ 0\\.025516828169261957\ \(0\)\
\-\ caliber\\:\\ 0\\.025283059246473553\ \(0\)\
\-\ level\\:\\ 0\\.024752653544190272\ \(0\)\
\-\ radiculopathy\\:\\ 0\\.023245546140402373\ \(0\)\
\-\ 52\\:\\ 0\\.02287858566294062\ \(0\)\
\-\ concerning\\:\\ 0\\.02253660846070436\ \(0\)\
\-\ neuro\\:\\ 0\\.022154769732172085\ \(0\)\
\-\ neoplastic\\:\\ 0\\.021974206871739607\ \(0\)\
\-\ descending\\:\\ 0\\.02096043982324184\ \(0\)\
\-\ potential\\:\\ 0\\.020678583206904935\ \(0\)\
\-\ fell\\:\\ 0\\.02054336987564903\ \(0\)\
\-\ therefore\\:\\ 0\\.020283391612336527\ \(0\)\
\-\ remainder\\:\\ 0\\.020241340106454536\ \(0\)\
\-\ short\\:\\ 0\\.020241340106454536\ \(0\)\
\-\ 14\\:\\ 0\\.01892292671717066\ \(0\)\
\-\ pathologic\\:\\ 0\\.01879570155142046\ \(0\)\
\-\ pending\\:\\ 0\\.018580525686179614\ \(0\)\
\-\ measures\\:\\ 0\\.01837418655654256\ \(0\)\
\-\ diameter\\:\\ 0\\.018066143713005897\ \(0\)\
\-\ i\\:\\ 0\\.017750325101650803\ \(0\)\
\-\ appear\\:\\ 0\\.01757486648302654\ \(0\)\
\-\ bony\\:\\ 0\\.01717264182135048\ \(0\)\
\-\ malformation\\:\\ 0\\.017127370113097385\ \(0\)\
\-\ persistent\\:\\ 0\\.017127370113097385\ \(0\)\
\-\ canal\\:\\ 0\\.01706021821454378\ \(0\)\
\-\ base\\:\\ 0\\.016821398406187772\ \(0\)\
\-\ structures\\:\\ 0\\.016532992386104093\ \(0\)\
\-\ extremity\\:\\ 0\\.015704316430364008\ \(0\)\
\-\ nerve\\:\\ 0\\.01547209108787591\ \(0\)\
\-\ required\\:\\ 0\\.015455907094408361\ \(0\)\
\-\ side\\:\\ 0\\.014876615586754125\ \(0\)\
\-\ inferior\\:\\ 0\\.01456942895155308\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.014515539688422549\ \(0\)\
\-\ three\\:\\ 0\\.014475498634909097\ \(0\)\
\-\ extending\\:\\ 0\\.01443577411477285\ \(0\)\
\-\ left\\:\\ 0\\.014413647275471076\ \(0\)\
\-\ by\\:\\ 0\\.014300210082863063\ \(0\)\
\-\ spine\\:\\ 0\\.014141223849273105\ \(0\)\
\-\ central\\:\\ 0\\.014128800788241\ \(0\)\
\-\ is\\:\\ 0\\.014127909004641349\ \(0\)\
\-\ body\\:\\ 0\\.013946048807482837\ \(0\)\
\-\ finding\\:\\ 0\\.01383950505044463\ \(0\)\
\-\ superior\\:\\ 0\\.01371227988469443\ \(0\)\
\-\ mr\\:\\ 0\\.01364421845199213\ \(0\)\
\-\ 6\\:\\ 0\\.012824724429019468\ \(0\)\
\-\ there\\:\\ 0\\.01278106086899486\ \(0\)\
\-\ demonstrated\\:\\ 0\\.01260010041435662\ \(0\)\
\-\ evaluation\\:\\ 0\\.01247356178807441\ \(0\)\
\-\ his\\:\\ 0\\.012376326772095136\ \(0\)\
\-\ through\\:\\ 0\\.012195763911662657\ \(0\)\
\-\ following\\:\\ 0\\.01218732541156356\ \(0\)\
\-\ weeks\\:\\ 0\\.01218732541156356\ \(0\)\
\-\ secondary\\:\\ 0\\.012005175711099535\ \(0\)\
\-\ y\\/o\\:\\ 0\\.011892608190048445\ \(0\)\
\-\ the\\:\\ 0\\.011810240401817279\ \(0\)\
\-\ cyst\\:\\ 0\\.011539553447367349\ \(0\)\
\-\ cm\\:\\ 0\\.01151736742621601\ \(0\)\
\-\ enhancement\\:\\ 0\\.011509993799613247\ \(0\)\
\-\ who\\:\\ 0\\.01119582115146584\ \(0\)\
\-\ prior\\:\\ 0\\.011025692322624943\ \(0\)\
\-\ surgery\\:\\ 0\\.010427130976684799\ \(0\)\
\-\ upper\\:\\ 0\\.01036221359481768\ \(0\)\
\-\ associated\\:\\ 0\\.010132977698028654\ \(0\)\
\-\ most\\:\\ 0\\.009913744430794352\ \(0\)\
\-\ exam\\:\\ 0\\.009433336381655971\ \(0\)\
\-\ treatment\\:\\ 0\\.008691542510557222\ \(0\)\
\-\ no\\:\\ 0\\.008647679906570874\ \(0\)\
\-\ also\\:\\ 0\\.008465425093819857\ \(0\)\
\-\ within\\:\\ 0\\.008191615117517998\ \(0\)\
\-\ male\\:\\ 0\\.007764851949183282\ \(0\)\
\-\ for\\:\\ 0\\.007327720086861458\ \(0\)\
\-\ to\\:\\ 0\\.00643821269009527\ \(0\)\
\-\ from\\:\\ 0\\.006363998558563881\ \(0\)\
\-\ not\\:\\ 0\\.006205118953477062\ \(0\)\
\-\ are\\:\\ 0\\.005853637550400009\ \(0\)\
\-\ at\\:\\ 0\\.005817905290611221\ \(0\)\
\-\ \\:\\:\\ 0\\.005679772944676709\ \(0\)\
\-\ pain\\:\\ 0\\.005244262148395652\ \(0\)\
\-\ or\\:\\ 0\\.005032777632983455\ \(0\)\
\-\ was\\:\\ 0\\.004966218704591391\ \(0\)\
\-\ of\\:\\ 0\\.004683569881326168\ \(0\)\
\-\ patient\\:\\ 0\\.004304482064906473\ \(0\)\
\-\ a\\:\\ 0\\.003985927656468355\ \(0\)\
\-\ on\\:\\ 0\\.0036376432782182317\ \(0\)\
\-\ \\(\\:\\ 0\\.0036299584233359826\ \(0\)\
\-\ \\)\\:\\ 0\\.00358561654328294\ \(0\)\
\-\ with\\:\\ 0\\.0023518427354751706\ \(0\)\
\-\ and\\:\\ 0\\.0018091357360021955\ \(0\)\
\-\ \\.\\:\\ 0\\.0016055066576689272\ \(0\)\
\-\ \\,\\:\\ 0\\.0013603520880265698\ \(0\)\
